860 related articles for article (PubMed ID: 19401623)
1. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
[TBL] [Abstract][Full Text] [Related]
2. Financial ties between DSM-IV panel members and the pharmaceutical industry.
Cosgrove L; Krimsky S; Vijayaraghavan M; Schneider L
Psychother Psychosom; 2006; 75(3):154-60. PubMed ID: 16636630
[TBL] [Abstract][Full Text] [Related]
3. Conflicts of interest and the quality of recommendations in clinical guidelines.
Cosgrove L; Bursztajn HJ; Erlich DR; Wheeler EE; Shaughnessy AF
J Eval Clin Pract; 2013 Aug; 19(4):674-81. PubMed ID: 23731207
[TBL] [Abstract][Full Text] [Related]
4. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
Choudhry NK; Stelfox HT; Detsky AS
JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700
[TBL] [Abstract][Full Text] [Related]
5. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
6. [The influence of the pharmaceutical industry on treatment guidelines].
Smulders YM; Thijs A
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2429-31. PubMed ID: 18064860
[TBL] [Abstract][Full Text] [Related]
7. Conflict of interest and professional medical associations: the North American Spine Society experience.
Schofferman JA; Eskay-Auerbach ML; Sawyer LS; Herring SA; Arnold PM; Muehlbauer EJ
Spine J; 2013 Aug; 13(8):974-9. PubMed ID: 23092717
[TBL] [Abstract][Full Text] [Related]
8. Conflict of interest in the debate over calcium-channel antagonists.
Stelfox HT; Chua G; O'Rourke K; Detsky AS
N Engl J Med; 1998 Jan; 338(2):101-6. PubMed ID: 9420342
[TBL] [Abstract][Full Text] [Related]
9. Commentary: Disclosure's failings: what is the alternative?
Kassirer JP
Acad Med; 2009 Sep; 84(9):1180-1. PubMed ID: 19707054
[TBL] [Abstract][Full Text] [Related]
10. The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate.
Rivkees SA
J Pediatr Endocrinol Metab; 2008 Jul; 21(7):607-9. PubMed ID: 18780592
[No Abstract] [Full Text] [Related]
11. Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan.
Murayama A; Kugo H; Senoo Y
BMJ Open; 2024 Jun; 14(6):e086396. PubMed ID: 38908845
[TBL] [Abstract][Full Text] [Related]
12. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
Elder K; Turner KA; Cosgrove L; Lexchin J; Shnier A; Moore A; Straus S; Thombs BD
CMAJ; 2020 Jun; 192(23):E617-E625. PubMed ID: 32538799
[TBL] [Abstract][Full Text] [Related]
13. Tripartite conflicts of interest and high stakes patent extensions in the DSM-5.
Cosgrove L; Krimsky S; Wheeler EE; Kaitz J; Greenspan SB; DiPentima NL
Psychother Psychosom; 2014; 83(2):106-13. PubMed ID: 24458102
[TBL] [Abstract][Full Text] [Related]
14. Strengthening conflict-of-interest policies in medicine.
Cosgrove L; Bursztajn HJ
J Eval Clin Pract; 2010 Feb; 16(1):21-4. PubMed ID: 19874437
[TBL] [Abstract][Full Text] [Related]
15. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
[TBL] [Abstract][Full Text] [Related]
16. Ethical management of conflict of interest: proposed standards for academic surgical societies.
Minter RM; Angelos P; Coimbra R; Dale P; de Vera ME; Hardacre J; Hawkins W; Kirkwood K; Matthews JB; McLoughlin J; Peralta E; Schmidt M; Zhou W; Schwarze ML
J Am Coll Surg; 2011 Nov; 213(5):677-82. PubMed ID: 21880513
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
[TBL] [Abstract][Full Text] [Related]
18. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
Chakrabarti A; Fleisher WP; Staley D; Calhoun L
Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
[TBL] [Abstract][Full Text] [Related]
19. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
[TBL] [Abstract][Full Text] [Related]
20. The corporate coauthor.
Fugh-Berman A
J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
